Amgen Inc. (NASDAQ: AMGN) upswings EPS estimates of $17.34 with $18.52 for the 2022 fiscal year. William Blair tagged NASDAQ: AMGN share rate with a rating of “hold” with $19.79 and $21.26 EPS expectation in 2023 and 2024 financial year, respectively.
NASDAQ: AMGN 12-month lowest is $177.05 and the highest at $264.97. This Monday, Amgen shares opened on the stock market with a price of $216.94. Subsequently, their fifty-day rolling average rate showed $240.17 and $239.20 two hundred-day average. Shareholders will be given $1.60/share on 16th November showing a 43.18% dividend payout quotient. The company also revealed its equity return of 98%, profit margin of 29.42% with a market cap at $127.06 billion.
JPMorgan Chase&Co decreased NASDAQ: AMGN shares objective price to $222 with a rating “neutral” on Thursday. Oppenheimer decreased the NASDAQ:AMGN share rate to a rating of “outperform” on 22nd October with a $275 price objective. Barclays also promoted the aim price of NASDAQ: AMGN shares of $250 into shares worth $242 and allotted a rating “equal-weight” on Thursday. On July 29th, Jefferies Financial Group promoted its rating to “buy” at a $300 price. Credit Suisse Group demoted share price to “outperform” with a $284 price objective. Currently, the stock market consensus has given a $253.58 target price with a rating “hold” to NASDAQ: AMGN.
Dir. Ronald Sugar earned $241,020,000 by selling 1,000 NASDAQ: AMGN shares at $241.02 EPS. Insiders of NASDAQ: AMGN has ownership of 0.36% of the entire stock.